Advertisement
Organisation › Details
Hansoh Pharmaceutical Group Co., Ltd. (incorporated inCayman Islands, Hong Kong Office)
Hansoh Pharma (3692:HK) is a leading biopharmaceutical company in China committed to discovering and developing life-changing medicines to help patients conquer serious diseases and disorders, together with its approximately 8,900 employees. Founded in 1995, Hansoh has fully integrated research and development, manufacturing and commercial capabilities, supporting a leadership position in central nervous system (CNS), oncology, anti-infectives and diabetes, among others. With approximately 1,400 professionals across R&D, Hansoh ranks top 2 in innovation among all biotech and pharmaceutical companies in China based on new molecular entity INDs submitted for clinical development since 2011. Hansoh Pharma’s 2018 revenue was approximately US$1.1 billion, representing a year-over-year growth of 25%. *
Start | 1995-01-01 established | |
Group | Hansoh Pharmaceutical (Group) | |
Today | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | |
Industry | pharmaceutical | |
Industry 2 | drug discovery | |
Person | Lyu, Aifeng (Hansoh Pharma 201909 President of Jiangsu HansoPharmaceutical Co., Ltd.) | |
Region | Cayman Islands (British Overseas Territory)_o | |
Country | United Kingdom (GB) | |
City | n. a. | |
Address record changed: 2023-08-07 | ||
Basic data | Employees | G: 5,001 to 10,000 (2019-09-11) |
Currency | USD | |
Annual sales | 1,100,000,000 (revenue (2018) 2018-12-31) | |
* Document for »About Section«: Atomwise, Inc.. (9/11/19). "Press Release: Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas". Shanghai & San Francisco, CA. | ||
Record changed: 2023-12-31 |
Advertisement
More documents for Hansoh Pharmaceutical (Group)
- [1] GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London....
- [2] GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London....
- [3] Silence Therapeutics plc. (10/15/21). "Press Release: Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence’s mRNAi GOLD™ Platform". London & Shanghai....
- [4] Atomwise, Inc.. (9/11/19). "Press Release: Atomwise Announces Largest China-US Collaboration for AI Drug Discovery". San Francisco, CA....
- [5] Atomwise, Inc.. (9/11/19). "Press Release: Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas". Shanghai & San Francisco, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top